Categories: Wire Stories

Sanjay Godhwani and David Bresnahan Appointed to New Executive Leadership Roles at Berkshire Hathaway Specialty Insurance

BOSTON & NEW YORK–(BUSINESS WIRE)–Berkshire Hathaway Specialty Insurance (BHSI) today announced Sanjay Godhwani has been named President, North America Region, and David Bresnahan will take on the role of Global Chief Operating Officer.

�Sanjay and Dave have been pivotal in the building of BHSI since our launch in 2013, helping to build our product lines, our talented team and our positive culture,” said Peter Eastwood, President and CEO, BHSI. “In their new roles, they will have a continued positive impact on our team and our ability to bring certainty and service excellence to our customers and distribution partners around the globe.”

Sanjay will be responsible for all North America Region underwriting and underwriting support groups, customer & broker engagement, and BHSI’s Global Catastrophe Engineering & Analytics group. Sanjay has more than 25 years of industry experience and is a fellow of the Casualty Actuarial Society. He continues to be based in Boston and can be reached at sanjay.godhwani@bhspecialty.com and 617.936.2904.

Dave has more than three decades of insurance industry experience. In his new role he will oversee real estate and administration, finance, audit, information technology and operations throughout BHSI’s global platform. He continues to be based in Boston and can be reached at david.bresnahan@bhspecialty.com and 617.936.2903.

Berkshire Hathaway Specialty Insurance (www.bhspecialty.com) provides commercial property, casualty, healthcare professional liability, executive and professional lines, transactional liability, surety, marine, travel, programs, accident and health, medical stop loss, homeowners, and multinational insurance. The actual and final terms of coverage for all product lines may vary. It underwrites on the paper of Berkshire Hathaway’s National Indemnity group of insurance companies, which hold financial strength ratings of A++ from AM Best and AA+ from Standard & Poor’s. Based in Boston, Berkshire Hathaway Specialty Insurance has offices in Atlanta, Boston, Chicago, Houston, Indianapolis, Irvine, Los Angeles, New York, San Francisco, San Ramon, Seattle, Stevens Point, Adelaide, Auckland, Brisbane, Cologne, Dubai, Dublin, Frankfurt, Hong Kong, Kuala Lumpur, London, Macau, Madrid, Manchester, Melbourne, Munich, Paris, Perth, Singapore, Sydney and Toronto.

For more information, contact info@bhspecialty.com.

Contacts

MEDIA:

JoAnn Lee

+1 617.936.2937

Alex

Recent Posts

Ryde Supercharges Mobility with AI-Driven App Revamp

SINGAPORE--(BUSINESS WIRE)--Ryde Group Ltd (“Ryde” or “the Company”) (NYSE American: RYDE), a leading technology company…

1 min ago

Verdantis Appoints Kumar Gaurav Gupta as Chief Executive Officer

PRINCETON, N.J.--(BUSINESS WIRE)--Verdantis, a pioneering leader in AI-powered data solutions, proudly announces the appointment of…

1 hour ago

Galaxy Macau, The World-class Luxury Integrated Resort Comes to the “Experience Macao Roadshow in Jakarta”

Providing Exclusive and Unique Experiences to Indonesian Tourists MACAU SAR - Media OutReach Newswire -…

1 hour ago

SK hynix and HLDS Jointly Developed Tube T31 and Haechi H02 Win Red Dot Design Award and Exhibit at COMPUTEX

SEOUL, South Korea--(BUSINESS WIRE)--Leading semiconductor company SK hynix today announced that its stick-type SSD, the…

2 hours ago

NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+

LONDON--(BUSINESS WIRE)--NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic…

2 hours ago

Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients

GUILFORD, Conn. & SHANGHAI--(BUSINESS WIRE)--Drug Farm announced today the U.S. Food and Drug Administration (FDA)…

2 hours ago